Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
ENROLLING BY INVITATION
NCT07417774
Liquid Biopsy in Glioblastoma Treated With Chemoradiation and an Oxygen Therapeutic
Sponsor: NuvOx LLC
View on ClinicalTrials.gov
Summary
The goal of this sub-study of the RESTORE trial is to identify biomarkers associated with tumor hypoxia, identify biomarkers that differentiate pseudoprogression from true progression, and correlate biomarkers with clinical outcomes.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
40
Start Date
2025-12-08
Completion Date
2030-12
Last Updated
2026-02-18
Healthy Volunteers
No
Conditions
Locations (4)
Center for Neurosciences
Tucson, Arizona, United States
Yale Cancer Center
New Haven, Connecticut, United States
Saint Luke's Cancer Institute
Kansas City, Missouri, United States
Duke University Medical Center
Durham, North Carolina, United States